US FDA – Page 56 – Express Pharma

Lupin gets EIR from USFDA for Aurangabad facility

Warning letter woes: Dr Reddy’s expects FDA inspection of AP plant by year-end

Alembic Pharma gets tentative nod from USFDA for glycemic control drug

Zydus Cadila launches insomnia drug in the US market

US FDA completes inspection of Strides Pharma Bengaluru plant

Indoco’s Goa Plant I receives Warning Letter from US FDA

Lupin aims to launch new products across geographies this fiscal

US FDA issues 5 observations to Dr Reddy’s plant in Hyderabad

Laurus Labs completes US FDA audit for Unit 4

Dr Reddy’s Laboratories plans to launch value-added drugs in US